Skip to main content

Table 5 Annual number of visits to health care professionals (excluding visits for administration)

From: Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece

Agent Hospital Dermatologist’s private office GP’s private office
Adalimumab 6 5 2
Etanercept 6 5 2
Infliximab 5 2 0
Ustekinumab 6 4 1